Authors
Loading...
Randomized trial compares metabolic impacts of diltiazem and atenolol in hypertensive individuals, highlighting important implications for diabetes risk.
Pollare et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: